Abstract
Comparative genomic hybridization (CGH) was applied to squamous cellcarcinomas (SCC) of the lung to define chromosomal imbalances that are associated with the metastatic phenotype. In total, 64 lung SCC from 50 patients were investigated, 25 each with or without evidence of metastasis formation. The chromosomal imbalances summarized by a CGH histogram of the 50 cases revealed deletions most frequently on chromosomes 1p21–p31, 2q34–q36, 3p, 4p, 4q, 5q, 6q14–q24, 8p, 9p, 10q, 11p12–p14, 13q13–qter, 18q12–qter and 21q21. DNA over-representations were most pronounced for chromosomes 1q11–q25, 1q32–q41, 3q, 5p, 8q22–qter, 11q13, 12p, 17q21–q22, 17q24–q25, 19, 20q and 22q. In ten cases, paired samples of primaries and at least one metastasis were analysed. The comparison revealed a considerable chromosomal instability and genetic heterogeneity; however, the CGH pattern indicated a clonal relationship in each case. The difference in histograms from the metastatic and non-metastatic tumour groups was most useful in pinpointing chromosomal imbalances associated with the metastatic phenotype, indicating that the deletions at 3p12–p14, 3p21, 4p15–p16, 6q24–qter, 8p22–p23, 10q21–qter and 21q22, as well as the over-representations at 1q21–q25, 8q, 9q34, 14q12 and 15q12–q15, occurred significantly more often in the metastatic tumour group. The comparison of the paired samples confirmed these findings in individual cases and suggested distinct genetic changes, in particular the extension of small interstitial deletions, during tumour progression. Importantly, metastasis-associated lesions were frequently detectable in the primary tumour providing a method of identifying patients at risk for tumour dissemination. Individual profiles and histograms are accessible at our web site http://amba.charite.de/cgh. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alers JC, Krijtenburg PJ, Rosenberg C, Hop WC, Verkerk AM, Schroder FH, van der Kwast TH, Bosman FT and van Dekken H (1997) Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone. Lab Invest 77: 437–448
Bockmühl U, Petersen S, Schmidt S, Wolf G, Jahnke V, Dietel M and Petersen I (1997) Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Res 57: 5213–5216
Brison O (1993) Gene amplification and tumor progression. Biochim Biophys Acta 1155: 25–41
Gronwald J, Storkel S, Holtgreve-Grez H, Hadaczek P, Brinkschmidt C, Jauch A, Lubinski J and Cremer T (1997) Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Cancer Res 57: 481–487
Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD and Gazdar AF (1995) Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273: 558–563
Ichikawa T, Nihei N, Kuramochi H, Kawana Y, Killary AM, Rinker-Schaeffer CW, Barrett C, Isaacs JT, Kugoh H, Oshimura M and Shimazaki J (1996) Metastasis suppressor genes for prostate cancer. Prostate Suppl 6: 31–35
Isola J, de Vries S, Chu L, Ghazvini S and Waldman FM (1994) Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin embedded tumor samples. Am J Pathol 145: 1301–1308
Joos S, Bergerheim US, Pan Y, Matsuyama H, Bentz M, du Manoir S and Lichter P (1995) Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes Cancer 14: 267–276
Kirchhoff M, Gerdes T, Rose H, Maahr J, Ottesen AM and Lundsteen C (1998) Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals. Cytometry 31: 163–173
Kohno T, Kawanishi M, Matsuda S, Ichikawa H, Takada M, Ohki M, Yamamoto T and Yokota J (1998) Homozygous deletion and frequent allelic loss of the 21q11.1–q21.1 region including the ANA gene in human lung carcinoma. Genes Chromosomes Cancer 21: 236–243
Kuukasjarvi T, Karhu R, Tanner M, Kahkonen M, Schaffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP and Isola J (1997) Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 57: 1597–1604
Levin NA, Brzoska P, Gupta N, Minna JD, Gray JW and Christman MF (1994) Identification of frequent novel genetic alterations in small cell lung carcinoma. Cancer Res 54: 5086–5091
Levin NA, Brzoska PM, Warnock ML, Gray JW and Christman MF (1995) Identification of novel regions of altered DNA copy number in small cell lung tumors. Genes Chromosomes Cancer 13: 175–185
Moore DHII, Pallavicini M, Cher ML and Gray JW (1997) A t-statistic for objective interpretation of comparative genomic hybridization (CGH) profiles. Cytometry 28: 183–190
Paredes-Zaglul A, Kang JJ, Essig YP, Mao W, Irby R, Wloch M and Yeatman TJ (1998) Analysis of colorectal cancer by comparative genomic hybridization: evidence for induction of the metastatic phenotype by loss of tumor suppressor genes. Clin Cancer Res 4: 879–886
Petersen I, Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, Reichel MB, Ried T and Dietel M (1997 a) Small cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer 75: 79–86
Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, Schwendel A, Langreck H, Gellert K, Reichel M, Just K, du Manoir S, Cremer T, Dietel M and Ried T (1997 b) Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 57: 2331–2335
Petersen S, Wolf G, Bockmühl U, Gellert K, Dietel M and Petersen I (1998a) Allelic loss on chromosome 10q in human lung cancer: Association with tumor progression and metastatic phenotype. Br J Cancer 77: 270–276
Petersen S, Rudolf J, Bockmühl U, Gellert K, Wolf G, Dietel M and Petersen I (1998b) Distinct regions of allelic imbalance on chromosome 10q22–q26 in squamous cell carcinomas of the lung. Oncogene 17: 449–454
Pisani P, Parkin DM and Ferlay J (1993) Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55: 891–903
Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schröck E, du Manoir S and Cremer T (1994) Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res 54: 1801–1806
Roth K, Wolf G, Dietel M and Petersen I (1997) Image analysis for comparative genomic hybridization based on a karyotyping program for Windows. Anal Quant Cytol Histol 19: 461–474
Schwendel A, Langreck H, Reichel M, Schröck E, Ried T, Dietel M and Petersen I (1997) Primary small cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations. Int J Cancer (Pred Oncol) 74: 86–93
Sekido Y, Fong KM and Minna JD (1998) Progress in understanding the molecular pathogenesis of human lung cancer. Biochim Biophys Acta 1378: F21–F59
Tarkkanen M, Karhu R, Kallioniemi A, Elomaa I, Kivioja AH, Nevalainen J, Bohling T, Karaharju E, Hyytinen E and Knuutila S (1995) Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res 55: 1334–1338
Welch DR, Chen P, Miele ME, McGary CT, Bower JM, Weissman BE and Stanbridge EJ (1994) Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene 9: 255–262
WHO (1981). Histological typing of lung tumors, WHO: Geneva
Wick W, Petersen I, Schmutzler RK, Wolfarth B, Lenartz D, Bierhoff E, Hümmerich J, Müller DJ, Stangl AP, Schramm J, Wiestler OD and von Deimling A (1996) Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. Oncogene 12: 973–978
Wu CL, Roz L, Sloan P, Read AP, Holland S, Porter S, Scully C, Speight PM and Thakker N (1997) Deletion mapping defines three discrete areas of allelic imbalance on chromosome arm 8p in oral and oropharyngeal squamous cell carcinomas. Genes Chromosomes Cancer 20: 347–353
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Petersen, S., Aninat-Meyer, M., Schlüns, K. et al. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer 82, 65–73 (2000). https://doi.org/10.1054/bjoc.1999.0878
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.0878
Keywords
This article is cited by
-
FADD as a key molecular player in cancer progression
Molecular Medicine (2022)
-
Chromatin accessibility promotes hematopoietic and leukemia stem cell activity
Nature Communications (2020)
-
A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population
The Pharmacogenomics Journal (2017)
-
Inherent variability of cancer-specific aneuploidy generates metastases
Molecular Cytogenetics (2016)
-
Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma
Tumor Biology (2014)